C. Atzori

发表

Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients

E. Clementi, A. Giacomelli, M. Galli, 2017, BMC Infectious Diseases.

Second-Line Salvage Treatment of AIDS-Associated Pneumocystis jirovecii Pneumonia: A Case Series and Systematic Review

T. Benfield, Robert F Miller, J. Helweg-Larsen, 2008, Journal of acquired immune deficiency syndromes.

Update on Pneumocystis carinii f. sp.hominis Typing Based on Nucleotide Sequence Variations in Internal Transcribed Spacer Regions of rRNA Genes

J. Lundgren, Baozheng Li, Ja Lu, 1998, Journal of Clinical Microbiology.

Dihydropteroate Synthase Gene Mutations in Pneumocystis and

M. Rabodonirina, T. Benfield, Robert F Miller, 2004 .

A Case of Pneumocystis jiroveci Pneumonia in X-Linked Agammaglobulinaemia Treated with Immunosuppressive Therapy: A Lesson for Immunologists

A. Esposito, M. Marziali, A. Cargnel, 2006, International Archives of Allergy and Immunology.

Human immunodeficiency virus protease inhibitors and Pneumocystis carinii.

A. Cargnel, C. Atzori, 2002, The Journal of infectious diseases.

In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.

E. Angeli, V. Micheli, A. Cargnel, 2000, The Journal of infectious diseases.

Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase inhibitors in vitro.

M. Scaglia, E. Angeli, A. Bruno, 1999, Parasite.

Pneumocystis carinii diagnosis: an update.

E. Angeli, V. Micheli, A. Cargnel, 2000, International journal of antimicrobial agents.

P. carinii DNA Detected by ITSs Nested PCR in Serum and PBMC of AIDS Patients with PCP

E. Angeli, G. Orlando, A. Cargnel, 1996, The Journal of eukaryotic microbiology.

Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimens.

Ja Lu, S. Queener, J. Smith, 1995, The Journal of infectious diseases.

Pneumocystis carinii pneumonia and tuberculosis in Tanzanian patients infected with HIV.

M. Scaglia, S. Gatti, A. Bruno, 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Combined use of blood and oropharyngeal samples for noninvasive diagnosis ofPneumocystis carinii pneumonia using the polymerase chain reaction

E. Angeli, G. Orlando, A. Cargnel, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Biomolecular techniques to detect Pneumocystis carinii f. sp. hominis pneumonia in patients with acquired immunodeficiency syndrome.

E. Angeli, V. Micheli, A. Cargnel, 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Prevalence of Various Pneumocystis carinii sp. f. hominis Types in Different Geographical Locations

Baozheng Li, James W. Smith, Jang-Jih Lu, 1996, The Journal of eukaryotic microbiology.

Emerging aspects related to the application of biomolecular techniques to the diagnosis of Pneumocystis carinii pneumonia: our experience with ITSs primers.

E. Angeli, V. Micheli, A. Cargnel, 1998, FEMS immunology and medical microbiology.

XXI. Current in vitro culture systems for Pneumocystis

E. Dei‐Cas, E. Aliouat, M. Bartlett, 1998 .

Effectiveness of aminosidine (paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial.

R. Maserati, P. Olliaro, M. Scaglia, 1994, The Journal of infectious diseases.

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.

T. Benfield, Robert F Miller, J. Helweg-Larsen, 2009, The Journal of antimicrobial chemotherapy.

Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii

M. Scaglia, M. Ghione, A. Bruno, 1993, Antimicrobial Agents and Chemotherapy.

Opportunistic and non-opportunistic parasites in HIV-positive and negative patients with diarrhoea in Tanzania.

E. Pozio, P. Rossi, M. Scaglia, 1995, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

Efficacy evidences in prevention of HIV infection in developing countries. A critical appraisal from population-based studies

P. Bonfanti, G. Rizzardini, L. Carenzi, 2009 .

Clinical features and outcomes of HIV patients with coronavirus disease 2019

A. Giacomelli, D. Cattaneo, A. Riva, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-pathogenic entamoeba histolytica in Italian HIV-infected homosexuals.

M. Cusini, M. Scaglia, S. Gatti, 1992, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Intestinal capillariasis (Capillaria philippinensis) acquired in Indonesia: a case report.

A. Malfitano, M. Scaglia, A. Bruno, 1992, The American journal of tropical medicine and hygiene.

Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens.

M. Clerici, G. Fantoni, D. Trabattoni, 2003, The Journal of antimicrobial chemotherapy.

Lyme borreliosis incidence in Lombardy, Italy (2000-2015): Spatiotemporal analysis and environmental risk factors.

M. Gismondo, S. Antinori, G. Cislaghi, 2019, Ticks and tick-borne diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

The Non‐Peptidic HIV Protease Inhibitor Tipranavir and Two Synthetic Peptidomimetics (TS98 and TS102) Modulate Pneumocystis carinii Growth and Proteasome Activity of HEL299 Cell Line

A. Tossi, M. Groettrup, M. Kremer, 2006, The Journal of eukaryotic microbiology.

Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance

Kristina Crothers, Thomas Benfield, M. Rabodonirina, 2004, Emerging infectious diseases.

Translation, Cross-Cultural Adaptation, and Preliminary Validation of the Transsexual Voice Questionnaire for Male-to-Female Transsexuals (I-TVQMtF) Into Italian.

A. Schindler, F. Mozzanica, M. Benazzo, 2020, Journal of voice : official journal of the Voice Foundation.

HIV-1 and parasitic infections in rural Tanzania.

M. Scaglia, S. Gatti, A. Bruno, 1993, Annals of tropical medicine and parasitology.

Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan

M. Ciccozzi, G. Zehender, C. Balotta, 2020, Sexually Transmitted Infections.

In vitro activity of amprenavir against Pneumocystis carinii.

G. Fantoni, A. Cargnel, A. Valerio, 2001, International journal of antimicrobial agents.

Current in vitro culture systems for Pneumocystis.

E. Dei‐Cas, E. Aliouat, M. Bartlett, 1998, FEMS immunology and medical microbiology.

Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19

A. Giacomelli, D. Cattaneo, A. Riva, 2020 .

Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation.

C. Fìlice, D. Cattaneo, C. Gervasoni, 2019, Therapeutic drug monitoring.

HIV Protease Inhibitors and Pneumocystis

G. Fantoni, A. Cargnel, A. Valerio, 2004 .

cART durability and causes for treatment switching or discontinuation in HIV-positive patients older than 50 years of age.

E. Ricci, E. Angeli, A. Zambelli, 2010, Journal of acquired immune deficiency syndromes.

Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice

A. d’Arminio Monforte, E. Foglia, L. Ferrario, 2020, Health Economics Review.

Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii.

C. Beard, J. Kovacs, G. Kutty, 2002, The Journal of infectious diseases.

New trend in the epidemiology of Pneumocystis carinii pneumonia (PCP) among AIDS patients.

E. Angeli, V. Micheli, A. Cargnel, 1999, The Journal of eukaryotic microbiology.

Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient.

M. Regazzi, P. Villani, A. Cargnel, 2003, AIDS.

Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?

G. Rizzardini, A. Capetti, S. Digiambenedetto, 2019, Open forum infectious diseases.

Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma

E. Clementi, D. Cattaneo, N. Charbe, 2016, Therapeutic drug monitoring.

HIV+ patients and gender differences: evidence from an Italian cohort

E. Foglia, L. Ferrario, D. Croce, 2016 .

Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.

J. Kovacs, Liang Ma, G. Fantoni, 2002, The Journal of infectious diseases.

Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates.

J. Kovacs, G. Kutty, C. Ripamonti, 2009, The Journal of infectious diseases.

Genotyping of Pneumocystis jiroveci Pneumonia in Italian AIDS Patients: Clinical Outcome Is Influenced by Dihydropteroate Synthase and Not by Internal Transcribed Spacer Genotype

G. Fantoni, P. Duca, F. Mazza, 2007, Journal of acquired immune deficiency syndromes.

DHPS‐Mutated Isolates of Pneumocystis jirovecii from HIV‐Infected Individuals: Analysis of Related ITS Genotypes

G. Fantoni, F. Mazza, A. Cargnel, 2006, Journal of Eukaryotic Microbiology.

No Correlation Between ITS Genotypes and DHPS Mutations

G. Fantoni, F. Mazza, A. Cargnel, 2004 .

P.carinii host specificity: attempt of cross infections with human derived strains in rats.

E. Angeli, V. Micheli, A. Cargnel, 1999, The Journal of eukaryotic microbiology.

Detection of a Proteasome in Pneumocystis carinii and its Modulation by Specific Proteasome Inhibitors

M. Piccinini, M. T. Rinaudo, F. Mazza, 2006, The Journal of eukaryotic microbiology.

Blackwater fever after halofantrine

G. Orlando, A. Cargnel, C. Atzori, 1996, The Lancet.